Copyright © 2002 by the European Society of Cardiology.
Letters to the Editor
Beta-blockers in chronic heart failure
Medizinische Universitätsklinik, Abteilung für Kardiologie, Auenbruggerplatz 15, A-8036, Graz, Austria
References
- Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001;22:15271560
[Free Full Text] - Metra M, Nardi M, Giubbini R, dei Cas L. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1994;24:16781687[Abstract]
- Krum H, Sackner-Bernstein JD, Goldsmith RL. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation. 1995;92:14991506
[Abstract/Free Full Text] - Kukin ML, Kalman J, Charney RH. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure. Circulation. 1999;99:26452651
[Abstract/Free Full Text] - Sanderson JE, Chan SKW, Yip G. Beta-blockade in heart failure. A comparison of carvedilol with metoprolol. J Am Coll Cardiol. 1999;34:15221528
[Abstract/Free Full Text] - Metra M, Giubbini R, Nodari S, Boldi E, Modena MG, dei Cas L. Differential effects of beta-blockers in patients with heart failure. Circulation. 2000;102:546551
[Abstract/Free Full Text] - Genth-Zotz S, Zotz RJ, Sigmund M. Metoprolol in patients with mild to moderate heart failure: effects on ventricular function and cardiopulmonary exercise testing. Eur J Heart Fail. 2000;2:175181
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
C. Seiler Management and follow up of prosthetic heart valves Heart, July 1, 2004; 90(7): 818 - 824. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
